Synapto-protective drugs evaluation in reconstructed neuronal network. - Wikidata - wikimedia - TriplyDB

Synapto-protective drugs evaluation in reconstructed neuronal network.

Synapto-protective drugs evaluation in reconstructed neuronal network.

http://www.wikidata.org/entity/Q34970628

about

Low piconewton towing of CNS axons against diffusing and surface-bound repellents requires the inhibition of motor protein-associated pathways.Cerebrospinal fluid levels of inflammation, oxidative stress and NAD+ are linked to differences in plasma carotenoid concentrations.Inducing microscopic thermal lesions for the dissection of functional cell networks on a chip.Double-Edge Sword of Sustained ROCK Activation in Prion Diseases through Neuritogenesis Defects and Prion Accumulation Rabies Virus Infection Induces the Formation of Stress Granules Closely Connected to the Viral Factories.Microfluidic platforms for the investigation of intercellular signalling mechanisms.Image Informatics Strategies for Deciphering Neuronal Network Connectivity.β-amyloid induces a dying-back process and remote trans-synaptic alterations in a microfluidic-based reconstructed neuronal network.A viral peptide that targets mitochondria protects against neuronal degeneration in models of Parkinson's disease.Microfluidic platforms for the study of neuronal injury in vitro.Neurotoxicity of the Cyanotoxin BMAA Through Axonal Degeneration and Intercellular Spreading.Dysregulated Neurotransmission induces Trans-synaptic degeneration in reconstructed Neuronal Networks

P2860

Q30601245-96F296F7-E892-4E72-A761-131620D2CD3F Q33895668-31CA2886-951A-4B03-8987-2211BA65F40C Q35378488-AEF8E1D9-068F-48FB-ACBB-18C3CC48AFBB Q35737668-B20A08FC-994B-41A2-8791-A88D3F29A718 Q36165348-F533DD9E-9590-4EAB-8FF2-6F1DF9AF6760 Q38252625-AA6916ED-4FF6-47ED-8E26-C8A77283C781 Q38840300-F68DE370-EEA9-46B8-A785-DCE38F090E51 Q41861213-B51F78D4-C565-483A-8F54-2F39293C32D8 Q42183169-ED91DB83-BC66-4F59-953A-A4B955035F14 Q47240527-05031FAC-B712-496C-A699-A1A7192C5D01 Q50495346-0760D29D-EF8D-44BB-BB3F-D98A0693670F Q58803573-47017EA4-247B-4FE3-B048-FD057393E567

P2860

Synapto-protective drugs evaluation in reconstructed neuronal network.

http://www.wikidata.org/entity/Q34970628

description

2013 nî lūn-bûn

@nan

2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

name

Synapto-protective drugs evaluation in reconstructed neuronal network.

@ast

Synapto-protective drugs evaluation in reconstructed neuronal network.

@en

Synapto-protective drugs evaluation in reconstructed neuronal network.

@nl

type

label

Synapto-protective drugs evaluation in reconstructed neuronal network.

@ast

Synapto-protective drugs evaluation in reconstructed neuronal network.

@en

Synapto-protective drugs evaluation in reconstructed neuronal network.

@nl

prefLabel

Synapto-protective drugs evaluation in reconstructed neuronal network.

@ast

Synapto-protective drugs evaluation in reconstructed neuronal network.

@en

Synapto-protective drugs evaluation in reconstructed neuronal network.

@nl

P1433

Q34970628-B142E507-14B3-463F-B131-BEEA073DDEC8

P1476

Q34970628-D3849222-E5DA-4827-9D11-E48E1B3DD9AC

P2093

Q34970628-054110CB-BA56-40E2-8921-FD1185D7DCE4

Q34970628-09DBF00E-94EF-4A85-97DB-83DC7CF9E19E

Q34970628-38E1C389-51B1-46FD-8426-E610DA217234

Q34970628-87E76074-61E0-4BB5-9AEF-EEE08CB671B3

Q34970628-9EC19230-6A58-4324-89B3-5ABECD5582FC

Q34970628-CB4A7336-5A01-4F57-87EC-C4DE37564FAF

Q34970628-E64B2BE5-A792-431D-BAA4-F43100C8CD39

Q34970628-FC2083F3-157C-4332-A994-10E19194160F

P2860

Q34970628-06004387-3520-4D17-AB8B-3F81FE18078E

Q34970628-0AB96E8C-09AF-49F5-8891-F1CF35A7C26C

Q34970628-0C3460C3-EA41-4777-B642-690E63169EB2

Q34970628-0E41D323-62BF-4AA0-B34E-FCE788EDEA6A

Q34970628-0F49AA07-14B9-47A9-83C1-564C98C7DF72

Q34970628-13E25CC0-E102-4583-879D-F3DD8797CA12

Q34970628-13F4038C-C570-49B2-969F-FCF527AB835B

Q34970628-15089A7C-8689-4686-AD0E-1130577051D7

Q34970628-15B793B5-ACAC-429C-A687-5A2A63C63BE2

Q34970628-18DDFEA4-99D7-4C54-807A-BB1CA6C58210

P304

Q34970628-0D7EE40E-A525-415D-996E-12986C2BBB27

P31

Q34970628-3BBD3C30-FEB6-4231-AD2E-9A9665B7E46E

P356

Q34970628-FFC235BB-9F23-498E-A45D-4503BCCA8F82

P407

Q34970628-C61FEEB8-6987-4B9D-8E08-4108F6EA4BA2

P433

Q34970628-92C43A7A-D787-45A1-8D65-586FF75A628C

P478

Q34970628-8E37EAD7-09B2-414B-A6FB-534E89318544

P50

Q34970628-28959E4B-4A03-4771-97B0-0B0FE487DF6B

Q34970628-FA9D32E7-3317-46F7-AC1B-A495C4FC5BF7

P577

Q34970628-96B88D89-7CA7-49C5-9976-1366C10335F0

P5875

Q34970628-62D707F9-C8B3-4F48-9DDD-C12C2646452C

P698

Q34970628-0EAB3482-BCB1-4602-B0F1-341C313ABF13

P932

Q34970628-231FEFE9-783A-4DB6-A0EA-6EA45905956A

P356

JOURNAL.PONE.0071103

P1433

P1476

Synapto-protective drugs evaluation in reconstructed neuronal network.

@en

P2093

Aurélie Alleaume-Butaux

http://www.w3.org/2001/XMLSchema#string

Benjamin Lassus

http://www.w3.org/2001/XMLSchema#string

Benoit Schneider

http://www.w3.org/2001/XMLSchema#string

Bernard Brugg

http://www.w3.org/2001/XMLSchema#string

Bérangère Deleglise

http://www.w3.org/2001/XMLSchema#string

Johannes J Hjorth

http://www.w3.org/2001/XMLSchema#string

Maéva Vignes

http://www.w3.org/2001/XMLSchema#string

Vaneyssa Soubeyre

http://www.w3.org/2001/XMLSchema#string

P2860

AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity

Soluble axoplasm enriched from injured CNS axons reveals the early modulation of the actin cytoskeleton

Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans

A Network Diffusion Model of Disease Progression in Dementia

Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension

Neurodegenerative diseases target large-scale human brain networks

Stages in the development of Parkinson's disease-related pathology

Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration

Wallerian-like degeneration of central neurons after synchronized and geometrically registered mass axotomy in a three-compartmental microfluidic chip

Caspase-3 activation via mitochondria is required for long-term depression and AMPA receptor internalization.

P304

e71103

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0071103

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Jean-Michel Peyrin

Jean-Louis Viovy

P577

2013-08-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

256102610

http://www.w3.org/2001/XMLSchema#string

P698

23976987

http://www.w3.org/2001/XMLSchema#string

P932

3745451

http://www.w3.org/2001/XMLSchema#string